PARENTERAL FORMULATION OF NIMODIPINE, A PROCESS FOR ITS PREPARATION AND ITS USE FOR CONTROLLING DISEASES

摘要

23189-5731 A parenteral formulation comprising about a) 0.01-0.4% by weight of nimodipine, relative to 100 parts by weight or a solvent comprising about b) 30-70% by weight of water 15-40% by weight of propylene glycol and/or polyethylene glycol, and 15-30% by weight of ethanol and, where appropriate, customary auxiliaries and/or additives.